Sign in or Register
  • Home
  • ERF
  • Mouse Anti-ERF Recombinant Antibody (1E5)

Mouse Anti-ERF Recombinant Antibody (1E5) (V2LY-0825-LY694)

See all ERF antibodies
Go to compare Compare Online Inquiry
Datasheet
SDS
Request for COA
Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal
Mouse
Clone
1E5
Application
WB, ELISA
Immunogen
ERF (aa 181-290) partial recombinant protein.
Host Species
Mouse
Specificity
Human, Mouse, Rat
Antibody Isotype
IgG2a, κ
Clonality
Monoclonal Antibody

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Buffer
PBS
Preservative
None
Concentration
Batch dependent
Purity
> 95% Purity determined by SDS-PAGE.
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.
More Infomation

Target

Full Name
Ets2 repressor factor
Entrez Gene ID
Human2077
Mouse13875
Rat292721
UniProt ID
HumanP50548
MouseP70459
RatD3ZJW0
Research Area
Potent transcriptional repressor that binds to the H1 element of the Ets2 promoter. May regulate other genes involved in cellular proliferation. Required for extraembryonic ectoderm differentiation, ectoplacental cone cavity closure, and chorioallantoic attachment (By similarity).

May be important for regulating trophoblast stem cell differentiation (By similarity).
Biological Process
Cell differentiation Source: GO_Central
Negative regulation of transcription by RNA polymerase II Source: GO_Central
Regulation of transcription by RNA polymerase II Source: GO_Central
Cellular Location
Nucleus
Involvement in disease
Craniosynostosis 4 (CRS4):
A primary abnormality of skull growth involving premature fusion of one or more cranial sutures. The growth velocity of the skull often cannot match that of the developing brain resulting in an abnormal head shape and, in some cases, increased intracranial pressure, which must be treated promptly to avoid permanent neurodevelopmental disability.
Chitayat syndrome (CHYTS):
An autosomal dominant syndrome characterized by hyperphalangism, partial syndactyly, bilateral accessory phalanx resulting in shortened index fingers, hallux valgus, brachydactyly, facial anomalies, diffuse bronchomalacia, and respiratory distress at birth and in infancy.
PTM
Phosphorylated by multiple kinases including MAPK1/ERK2 at THR-526. Phosphorylation regulates the activity of ERF.

Tsiomita, S., Liveri, E. M., Vardaka, P., Vogiatzi, A., Skiadaresis, A., Saridis, G., ... & Thyphronitis, G. (2022). ETS2 repressor factor (ERF) is involved in T lymphocyte maturation acting as regulator of thymocyte lineage commitment. Journal of Leukocyte Biology.

Cannon-Albright, L. A., Teerlink, C. C., Stevens, J., Huang, F. W., Sipeky, C., Schleutker, J., ... & Trump, D. L. (2021). A Rare Variant in ERF (rs144812092) Predisposes to Prostate and Bladder Cancers in an Extended Pedigree. Cancers, 13(10), 2399.

Bao, X., Zhang, X., Wang, L., Wang, Z., Huang, J., Zhang, Q., ... & Xu, X. (2021). Epigenetic inactivation of ERF reactivates γ-globin expression in β-thalassemia. The American Journal of Human Genetics, 108(4), 709-721.

Yamada, M., Funato, M., Kondo, G., Suzuki, H., Uehara, T., Takenouchi, T., ... & Kosaki, K. (2021). Noonan syndrome‐like phenotype in a patient with heterozygous ERF truncating variant. Congenital Anomalies, 61(6), 226-230.

Vogiatzi, A., Baltsavia, I., Dialynas, E., Theodorou, V., Zhou, Y., Deligianni, E., ... & Mavrothalassitis, G. (2021). Erf affects commitment and differentiation of osteoprogenitor cells in cranial sutures via the retinoic acid pathway. Molecular and Cellular Biology, 41(8), e00149-21.

Yin, X., Zheng, X., Liu, M., Wang, D., Sun, H., Qiu, Y., ... & Shi, B. (2020). Exosomal miR‐663b targets Ets2‐repressor factor to promote proliferation and the epithelial–mesenchymal transition of bladder cancer cells. Cell Biology International, 44(4), 958-965.

Caro‐Contreras, A., Alcántara‐Ortigoza, M. A., Ahumada‐Pérez, J. F., & González‐del Angel, A. (2019). Molecular analysis provides further evidence that Chitayat syndrome is caused by the recurrent p.(Tyr89Cys) pathogenic variant in the ERF gene. American Journal of Medical Genetics Part A, 179(1), 118-122.

Glass, G. E., O'Hara, J., Canham, N., Cilliers, D., Dunaway, D., Fenwick, A. L., ... & Wilson, L. C. (2019). ERF‐related craniosynostosis: The phenotypic and developmental profile of a new craniosynostosis syndrome. American Journal of Medical Genetics Part A, 179(4), 615-627.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-ERF Recombinant Antibody (1E5)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols

Related Products

Mouse Anti-ERF Recombinant Antibody (CBFYE-1183) (CAT#: V2LY-0825-LY693)

Mouse Anti-ERF Recombinant Antibody (CBFYE-0254) (CAT#: V2LY-0825-LY692)

Mouse Anti-ERF Recombinant Antibody (3F11) (CAT#: CBMAB-A2700-LY)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry
Request bulk or custom quote Second antibody and isotype control

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

online inquiry
Online Inquiry